Literature DB >> 11929424

Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics.

T Sekiya1, H Yamada, M Yamaguchi, K Yamamoto, A Ishii, O Yoshie, Y Sano, A Morita, K Matsushima, K Hirai.   

Abstract

BACKGROUND: Cytokines liberated by TH2 cells play crucial roles in the pathogenesis of bronchial asthma. Recent studies have demonstrated that CC chemokine receptor (CCR)4 is preferentially expressed by TH2 cells. These facts suggest possible involvement of two CCR4-specific ligands i.e., thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), in the pathogenesis of bronchial asthma via recruitment of TH2 cells to inflammatory sites. We investigated the levels of TARC and MDC in the serum and induced sputum of asthmatics.
METHODS: The levels of TARC in the serum (46 asthmatics and 26 healthy subjects) and induced sputum (30 asthmatics and 6 healthy subjects) were measured using a highly sensitive ELISA system. The levels of eotaxin and MDC were also measured by ELISA.
RESULTS: TARC, but not MDC, was significantly increased in asthmatic sera (P<0.001). Although MDC was undetectable in the sputum of most cases by our assay system, sputum TARC was significantly increased (P=0.027).
CONCLUSIONS: The elevated TARC levels in asthmatics might be involved in the pathophysiology of asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929424     DOI: 10.1034/j.1398-9995.2002.5720256.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  31 in total

1.  iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Authors:  Everett H Meyer; Marc-André Wurbel; Tracy L Staton; Muriel Pichavant; Matthew J Kan; Paul B Savage; Rosemarie H DeKruyff; Eugene C Butcher; James J Campbell; Dale T Umetsu
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

2.  Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.

Authors:  Bart van Hartingsveldt; Ivo P Nnane; Esther Bouman-Thio; Matthew J Loza; Alexa Piantone; Hugh M Davis; Kevin J Petty
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

3.  Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.

Authors:  Florence Roufosse; Aurore de Lavareille; Liliane Schandené; Elie Cogan; Ann Georgelas; Lori Wagner; Liqiang Xi; Mark Raffeld; Michel Goldman; Gerald J Gleich; Amy Klion
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

4.  The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity.

Authors:  Gregory S Whitehead; Tie Wang; Laura M DeGraff; Jeffrey W Card; Sergio A Lira; Gerard J Graham; Donald N Cook
Journal:  Am J Respir Crit Care Med       Date:  2006-11-09       Impact factor: 21.405

5.  Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.

Authors:  Kristin J Carpenter; Cory M Hogaboam
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 6.  Personalised medicine and asthma diagnostics/management.

Authors:  Samuel J Wadsworth; Andrew J Sandford
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

7.  Variations in the human Th2-specific chemokine TARC gene.

Authors:  Takashi Sekiya; Yuichiro Tsunemi; Misato Miyamasu; Ken Ohta; Atsushi Morita; Hidehisa Saeki; Kouji Matsushima; Osamu Yoshie; Naoyuki Tsuchiya; Masao Yamaguchi; Kazuhiko Yamamoto; Kunihiko Tamaki; Koichi Hirai
Journal:  Immunogenetics       Date:  2003-01-09       Impact factor: 2.846

8.  Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.

Authors:  Claudia Jakubzick; Haitao Wen; Akihiro Matsukawa; Maya Keller; Steven L Kunkel; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 9.  Which biomarkers are effective for identifying Th2-driven inflammation in asthma?

Authors:  Zuzana Diamant; Ellen Tufvesson; Leif Bjermer
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

10.  Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.

Authors:  Mikiko Kanamori; Shinya Watanabe; Reiko Honma; Masayuki Kuroda; Shosuke Imai; Kenzo Takada; Naoki Yamamoto; Yukihiro Nishiyama; Yasushi Kawaguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.